Illumina (ILMN) P/E (2009 - 2026)
Illumina (ILMN) P/E from Jun 29, 2009 to Jul 21, 2026. The TTM Illumina (ILMN) P/E is 45.39. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Illumina (ILMN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 45.39 | +174.22% |
| 2025 | 16.55 | -271.67% |
| 2024 | -9.64 | +117.39% |
| 2023 | -4.44 | -43.32% |
| 2022 | -7.82 | -111.29% |
| 2021 | 69.29 | -21.40% |
| 2020 | 88.16 | +69.17% |
| 2019 | 52.11 | -10.31% |
| 2018 | 58.10 | +39.26% |
| 2017 | 41.72 | +0.83% |
| 2016 | 41.38 | -32.42% |
| 2015 | 61.23 | -42.37% |
| 2014 | 106.24 | -42.55% |
| 2013 | 184.95 | +169.69% |
| 2012 | 68.58 | +99.84% |
| 2011 | 34.32 | -52.11% |
| 2010 | 71.66 | -16.51% |
| 2009 | 85.83 | N/A |
Comparison Illumina (ILMN) P/E with competitors
Illumina (ILMN) P/E is 45.39.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -97.69% |
| MBAI | CheckCap Ltd | 1.71 | -96.23% |
| FONR | Fonar Corp | 15.48 | -65.90% |
| QGEN | Qiagen NV | 20.03 | -55.87% |
| DGX | Quest Diagnostics Inc | 22.47 | -50.49% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -47.41% |
| IQV | IQVIA Holdings Inc | 25.28 | -44.30% |
| A | Agilent Technologies Inc | 26.96 | -40.61% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -30.53% |
| MTD | Mettler-Toledo International Inc | 32.45 | -28.50% |
| MEDP | Medpace Holdings Inc | 32.55 | -28.29% |
| DHR | Danaher Corp | 38.55 | -15.06% |
| IDXX | Idexx Laboratories Inc | 40.58 | -10.60% |
| RVTY | Revvity Inc | 52.68 | +16.07% |
| VCYT | Veracyte Inc | 53.71 | +18.34% |
| ICLR | Icon Plc | 57.45 | +26.58% |
| SHC | Sotera Health Company | 74.08 | +63.22% |
| WAT | Waters Corp | 102.79 | +126.46% |